Proposed Data Collection Submitted for Public Comment and Recommendations, 14269-14271 [2022-05301]
Download as PDF
<![CDATA[
14269
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Sudden Death in the Young (SDY)
Case Registry (OMB Control No. 0920–
1092, Exp. 04/30/2022)—Revision—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Sudden Death in the Young (SDY) is
defined as a sudden and unexpected
death among an infant, child, or young
adults (up to age 20), which is not
explained by homicide, suicide,
overdose, or the result of an external
cause that was the only and obvious
reason for the fatal injury, or terminal
illnesses. Injury deaths where there may
have been an initiating natural cause
(e.g., drowning or death of the driver in
a motor vehicle accident, which may
have been triggered by an underlying
cardiac or neurological condition) are
also included in the definition.
SDY deaths are not systematically
monitored and estimates of the annual
incidence of SDY vary due to
differences in definitions,
inconsistencies in classifying cause,
variable age and study populations, and
differing case ascertainment
methodologies. Because standardized
information has not been collected on
the incidence, causes, and risk factors,
developing evidence-based prevention
measures has been challenging.
To address these gaps, CDC, in
collaboration with the National Heart,
Lung, and Blood Institute and the
National Institute of Neurological
Disorders and Stroke at the National
Institutes of Health, implemented the
SDY Case Registry. Standardized data
collected through the SDY Case Registry
has been used by the NIH and CDC
awardees to generate estimates of the
incidence of SDY; to elucidate risk
factors; and to develop evidence-based
prevention strategies for SDY. The SDY
Registry also creates infrastructure for
future research about previously
unknown or unrecognized risk factors
for, and causes of, these deaths.
This information collection request is
to extend OMB approval for the SDY
Registry. By continuing the prior work
of the SDY Registry, the information
collected under this request will allow
CDC to provide technical assistance to
awardees so they can improve their state
or local jurisdiction’s information on
SDY. This includes two additions to
their existing Child Death Review (CDR)
program: (1) Entering SDY information
from existing data sources (e.g., medical
records, autopsy reports) used during
CDR review into the established webbased NCFRP Case Reporting System;
and (2) convening clinicians with three
different types of expertise (pediatric
cardiology; pediatric neurology or
epileptology; and forensic pathology) to
conduct advanced clinical reviews of a
subset of SDY cases to allow for a more
thorough review of information
compiled, and to generate additional
data about the classification of the
death. The intended result will be data
that can establish incidence and guide
program and policy decisions at the
state/local jurisdiction levels.
CDC estimates that the participating
state/local jurisdictions will collect data
on approximately 720 SDY cases per
year. For participating state/local
jurisdictions, burden is estimated for
reporting required case information.
Based on historical program
information, it is estimated that
approximately half (360) of the 720
estimated SDY cases each year will
undergo an advanced clinical review
and classification of cause by a team of
three medical experts.
OMB approval is requested for three
years. The total estimated annual
burden is 511 hours which is a decrease
of 10 hours from the previously
approved information collection request
due to a decrease in the number of
participating states/local jurisdictions
from 14 to 13. There are no costs to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State or Local Health Department Personnel
Medical Experts ..............................................
State or Local Health Department Personnel
SDY Module I .................................................
Advanced Review ..........................................
SDY Module N ...............................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–05298 Filed 3–11–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0457; Docket No. CDC–2022–
0033]
BILLING CODE 4163–18–P
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Type of respondents
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
SUMMARY:
VerDate Sep<11>2014
17:51 Mar 11, 2022
Jkt 256001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
13
39
13
55
28
55
Average
burden per
response
(in hours)
10/60
15/60
10/60
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on an
information collection titled, Aggregate
Reports for Tuberculosis Program
Evaluation. The goal of the study is to
allow CDC to collect and monitor
indicators for key program activities,
such as finding tuberculosis infections
in recent contacts of cases and in other
high-risk persons likely to be infected,
and providing therapy for latent
E:\FR\FM\14MRN1.SGM
14MRN1
14270
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
tuberculosis infection, in an effort to
eliminate tuberculosis in the United
States.
CDC must receive written
comments on or before May 13, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0033 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
DATES:
To ensure the elimination of
tuberculosis in the United States, CDC
monitors indicators for key program
activities, such as finding tuberculosis
infections in recent contacts of cases
and in other persons likely to be
infected, and providing therapy for
latent tuberculosis infection. In 2000,
CDC implemented two program
evaluation reports for annual
submission: Aggregate report of followup and treatment for contacts of
tuberculosis cases, and Aggregate report
of targeted testing and treatment for
latent tuberculosis infection. The
respondents for these reports are the 67
state and local tuberculosis control
programs receiving federal cooperative
agreement funding through the CDC
Division of Tuberculosis Elimination
(DTBE). These reports emphasize
treatment outcomes, high-priority target
populations vulnerable to tuberculosis,
and electronic report entry and
submission to CDC through the National
Tuberculosis Indicators Project (NTIP), a
secure web-based system for program
evaluation data. No other federal agency
collects this type of national
tuberculosis data, and the aggregate
report of follow-up and treatment for
contacts of tuberculosis cases, and
aggregate report of targeted testing and
treatment for latent tuberculosis
infection are the only data source about
latent tuberculosis infection for
monitoring national progress toward
tuberculosis elimination with these
activities. CDC provides ongoing
assistance in the preparation and
utilization of these reports at the local
and state levels of public health
jurisdiction. CDC also provides
respondents with technical support for
the NTIP software.
CDC requests OMB approval for an
estimated 268 annual burden hours.
There is no cost to respondents other
than their time to participate.
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Aggregate Reports for Tuberculosis
Program Evaluation (OMB Control No.
0920–0457, Exp. 12/31/2022)—
Extension—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests an Extension of the
Aggregate Reports for Tuberculosis
Program Evaluation project, previously
approved under OMB Control No. 0920–
0457, for a period of three years. There
are no revisions to the report forms, data
definitions, or reporting instructions.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
jspears on DSK121TN23PROD with NOTICES1
Data clerks and Program Managers
(electronic).
Data clerks and Program Managers
(electronic).
Total ...........................................
VerDate Sep<11>2014
17:51 Mar 11, 2022
Number of
respondents
Form name
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
hours
Follow-up and Treatment of Contacts to Tuberculosis Cases Form.
Targeted Testing and Treatment for
Latent Tuberculosis Infection.
67
1
2
134
67
1
2
134
...........................................................
........................
........................
........................
268
Jkt 256001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–05301 Filed 3–11–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0765; Docket No. CDC–2022–
0032]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies to comment on proposed and/
or continuing information collections,
as required by the Paperwork Reduction
Act of 1995. This notice invites
comments on an information collection
titled, CDC’s Fellowship Management
System (FMS). CDC uses the
information collected to aid and
enhance the selection of fellowship
participants and host sites and to track
participant information that helps
strengthen the current, emerging, and
ever-changing public health workforce.
DATES: CDC must receive written
comments on or before May 13, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0032 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
jspears on DSK121TN23PROD with NOTICES1
SUMMARY:
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT:
To
request more information on the
VerDate Sep<11>2014
17:51 Mar 11, 2022
Jkt 256001
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Data collection for fellowship
programs using CDC’s Fellowship
Management System (OMB Control No.
0920–0765, Exp. 3/31/2023)—
Revision—Center for Surveillance,
Education, and Laboratory Services
(CSELS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Division of Scientific Education
and Professional Development (DSEPD/
CSELS) requests a three-year revision to
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
14271
continue the use of the CDC Fellowship
Management System (FMS) to collect
data under the approved OMB Control
Number (0920–0765). The mission of
DSEPD is to improve health outcomes
through a competent, sustainable, and
empowered public health workforce.
Professionals in public health,
epidemiology, medicine, economics,
information science, veterinary
medicine, nursing, public policy, and
other related professionals seek
opportunities, through CDC fellowships,
to broaden their knowledge and skills,
and to improve the science and practice
of public health. CDC fellows are
assigned to state, tribal, local, and
territorial public health agencies; federal
government agencies, including CDC
and Department of Health and Human
Services’ (HHS) operational divisions,
such as Centers for Medicare &
Medicaid Services; and to
nongovernmental organizations,
including academic institutions, tribal
organizations, and private public health
organizations.
CDC uses FMS to collect, process, and
manage data from nonfederal applicants
seeking training or public health
support services through CDC
fellowships. FMS is used to
electronically submit fellowship
applications, submit fellowship host site
proposals, track completion of
fellowship activities, and maintain
fellowship alumni directories online.
FMS is a flexible and robust electronic
information system standardized and
tailored for each CDC fellowship,
collecting only the minimum amount of
information needed. The system is
critical to streamlining data
management for CDC and reducing
burden for respondents. FMS is key to
CDC’s ability to protect the public’s
health by supporting training
opportunities that strengthen the public
health workforce.
The proposed Revision has two
purposes: (1) Increase the number of
likely respondents and (2) change the
software platform on which FMS
operates. The increase in likely
respondents is a result of increased
funding that will allow DSEPD to
expand many of the fellowships
managed through FMS. The change in
software platform will provide CDC
with an even more efficient, effective,
and secure electronic mechanism for
collecting, processing, and monitoring
fellowship information. The proposed
software platform is the Microsoft®
Power Platform® (Microsoft
Corporation, Cary, Washington).
Integration of the suite of Microsoft
tools for data management, analysis, and
visualization will allow CDC to access
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 87, Number 49 (Monday, March 14, 2022)]
[Notices]
[Pages 14269-14271]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05301]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-0457; Docket No. CDC-2022-0033]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on an information
collection titled, Aggregate Reports for Tuberculosis Program
Evaluation. The goal of the study is to allow CDC to collect and
monitor indicators for key program activities, such as finding
tuberculosis infections in recent contacts of cases and in other high-
risk persons likely to be infected, and providing therapy for latent
[[Page 14270]]
tuberculosis infection, in an effort to eliminate tuberculosis in the
United States.
DATES: CDC must receive written comments on or before May 13, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0033 by either of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Aggregate Reports for Tuberculosis Program Evaluation (OMB Control
No. 0920-0457, Exp. 12/31/2022)--Extension--National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests an Extension of the Aggregate Reports for Tuberculosis
Program Evaluation project, previously approved under OMB Control No.
0920-0457, for a period of three years. There are no revisions to the
report forms, data definitions, or reporting instructions.
To ensure the elimination of tuberculosis in the United States, CDC
monitors indicators for key program activities, such as finding
tuberculosis infections in recent contacts of cases and in other
persons likely to be infected, and providing therapy for latent
tuberculosis infection. In 2000, CDC implemented two program evaluation
reports for annual submission: Aggregate report of follow-up and
treatment for contacts of tuberculosis cases, and Aggregate report of
targeted testing and treatment for latent tuberculosis infection. The
respondents for these reports are the 67 state and local tuberculosis
control programs receiving federal cooperative agreement funding
through the CDC Division of Tuberculosis Elimination (DTBE). These
reports emphasize treatment outcomes, high-priority target populations
vulnerable to tuberculosis, and electronic report entry and submission
to CDC through the National Tuberculosis Indicators Project (NTIP), a
secure web-based system for program evaluation data. No other federal
agency collects this type of national tuberculosis data, and the
aggregate report of follow-up and treatment for contacts of
tuberculosis cases, and aggregate report of targeted testing and
treatment for latent tuberculosis infection are the only data source
about latent tuberculosis infection for monitoring national progress
toward tuberculosis elimination with these activities. CDC provides
ongoing assistance in the preparation and utilization of these reports
at the local and state levels of public health jurisdiction. CDC also
provides respondents with technical support for the NTIP software.
CDC requests OMB approval for an estimated 268 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Data clerks and Program Follow-up and 67 1 2 134
Managers (electronic). Treatment of
Contacts to
Tuberculosis
Cases Form.
Data clerks and Program Targeted Testing 67 1 2 134
Managers (electronic). and Treatment
for Latent
Tuberculosis
Infection.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 268
----------------------------------------------------------------------------------------------------------------
[[Page 14271]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-05301 Filed 3-11-22; 8:45 am]
BILLING CODE 4163-18-P
